BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1320 related articles for article (PubMed ID: 28058848)

  • 1. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.
    Winther-Jensen M; Hassager C; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Christensen EF; Kragholm K; Kjaergaard J
    Europace; 2018 Jul; 20(7):1129-1137. PubMed ID: 29016817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter Defibrillator Implantation Rates After Out of Hospital Cardiac Arrest: Are the Rates Guideline-Concordant?
    Ho EC; Cheskes S; Angaran P; Morrison LJ; Aves T; Zhan C; Ko DT; Dorian P;
    Can J Cardiol; 2017 Oct; 33(10):1266-1273. PubMed ID: 28867265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to acute coronary syndrome.
    Madhavan M; Friedman PA; Lennon RJ; Prasad A; White RD; Sriram CS; Gulati R; Gersh BJ
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest.
    Birnie DH; Sambell C; Johansen H; Williams K; Lemery R; Green MS; Gollob MH; Lee DS; Tang AS
    CMAJ; 2007 Jul; 177(1):41-6. PubMed ID: 17606938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-Hospital Cardiac Arrest in Patients With and Without Psychiatric Disorders: Differences in Use of Coronary Angiography, Coronary Revascularization, and Implantable Cardioverter-Defibrillator and Survival.
    Barcella CA; Mohr GH; Kragholm KH; Gerds TA; Jensen SE; Polcwiartek C; Wissenberg M; Lippert FK; Torp-Pedersen C; Kessing LV; Gislason GH; Søndergaard KB
    J Am Heart Assoc; 2019 Aug; 8(16):e012708. PubMed ID: 31423870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: role of cardiac conditions and noncardiac comorbidities.
    MacFadden DR; Tu JV; Chong A; Austin PC; Lee DS
    Heart Rhythm; 2009 Sep; 6(9):1289-96. PubMed ID: 19695966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Successful Resuscitation After Out-of-Hospital Cardiac Arrest and Temporal Trends in Survival and Comorbidity.
    Søholm H; Hassager C; Lippert F; Winther-Jensen M; Thomsen JH; Friberg H; Bro-Jeppesen J; Køber L; Kjaergaard J
    Ann Emerg Med; 2015 May; 65(5):523-531.e2. PubMed ID: 25544733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival.
    Schmidt M; Pedersen SB; Farkas DK; Hjortshøj SP; Bøtker HE; Nielsen JC; Sørensen HT
    Heart Rhythm; 2015 Sep; 12(9):2018-27. PubMed ID: 25937527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.
    Sredniawa B; Mazurek M; Lenarczyk R; Kowalski O; Kowalczyk J; Kalarus Z
    Future Cardiol; 2010 May; 6(3):315-23. PubMed ID: 20462338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
    Powell AC; Fuchs T; Finkelstein DM; Garan H; Cannom DS; McGovern BA; Kelly E; Vlahakes GJ; Torchiana DF; Ruskin JN
    Circulation; 1993 Sep; 88(3):1083-92. PubMed ID: 8353870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.
    Goldstein SA; Li S; Lu D; Matsouaka RA; Rymer J; Fonarow GC; de Lemos JA; Peterson E; Pokorney SD; Wang T; Al-Khatib SM
    Am J Cardiol; 2021 Jan; 138():26-32. PubMed ID: 33068540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
    Barsheshet A; Vamvouris T; Goldenberg I
    Expert Rev Med Devices; 2016 Jul; 13(7):627-32. PubMed ID: 27333818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
    Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.
    Miller AL; Gosch K; Daugherty SL; Rathore S; Peterson PN; Peterson ED; Ho PM; Chan PS; Lanfear DE; Spertus JA; Wang TY
    Am Heart J; 2013 Oct; 166(4):737-43. PubMed ID: 24093855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community.
    Narayanan K; Reinier K; Uy-Evanado A; Teodorescu C; Chugh H; Marijon E; Gunson K; Jui J; Chugh SS
    Circulation; 2013 Oct; 128(16):1733-8. PubMed ID: 24048201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.